Ranjit is a physician-scientist and biotech entrepreneur at the Yale School of Medicine. Clinically, Ranjit treats adult and pediatric primary CNS tumors, as well as brain metastases. He also runs Phase I and II clinical trials testing experimental therapeutics at Yale, which are largely based on discoveries from his own laboratory. His academic research has received international attention with major clinical implications, and he is regarded by many as an emerging leader in the brain tumor space. His laboratory has published findings in multiple high-impact journals, including Science Translational Medicine and Nature Genetics. Ranjit received his undergraduate degree in Molecular Biophysics and Biochemistry from Yale University, and both his MD and PhD from the Yale School of Medicine. He completed his medical internship, radiation oncology residency, and postdoctoral research studies at the Memorial Sloan Kettering Cancer Center.